Enterococcus faecalis cytolysin toxin

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 717-727

  Carniol, Karen ^a   Gilmore, Michael S ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877060001     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50046-9     Document Type: Chapter

References (71)

1. Basinger S.F., Jackson R.W. Bacteriocin (hemolysin) of Streptococcus zymogenes. The Journal of Bacteriology 1968, 96:1895-1902.
2. Bierbaum G., Szekat C., Josten M., Heidrich C., Kempter C., Jung G., Sahl H.G. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl.Environ.Microbiol. 1996, 62:385-392.
3. Booth M.C., Bogie C.P., Sahl H.G., Siezen R.J., Hatter K.L., Gilmore M.S. Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol. Microbiol. 1996, 21:1175-1184.
4. Booth M.C., Hatter K.L., Miller D., Davis J., Kowalski R., Parke D.W., Chodosh J., Jett B.D., Callegan M.C., Penland R., Gilmore M.S. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect. Immun. 1998, 66:356-360.
5. Brock T.D., Davie J.M. Probable identity of a group D hemolysin with a bacteriocine. J. Bacteriol. 1963, 86:708-712.
6. Brock T.D., Peacher B., Pierson D. Survey of the bacteriocins of enterococci. The Journal of Bacteriology 1963, 86:702-707.
7. Brotz H., Josten M., Wiedemann I., Schneider U., Gotz F., Bierbaum G., Sahl H.G. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin, and other lantibiotics. Mol. Microbiol. 1998, 30:317-327.
8. Chow J.W., Thal L.A., Perri M.B., Vazquez J.A., Donabedian S.M., Clewell D.B., Zervos M.J. Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis. Antimicrob. Agents Chemother. 1993, 37:2474-2477.
9. Clewell D.B. Bacterial sex pheromone-induced plasmid transfer. Cell 1993, 73:9-12.
10. Clewell D.B., Tomich P.K., Gawron-Burke M.C., Franke A.E., Yagi Y., An F.Y. Mapping of Streptococcus faecalis plasmids pAD1 and pAD2 and studies relating to transposition of Tn917. The Journal of Bacteriology 1982, 152:1220-1230.
11. Coburn P.S., Hancock L.E., Booth M.C., Gilmore M.S. A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin. Infect. Immun. 1999, 67:3339-3347.
12. Coburn, P.S., Pillar, C.M., Jett, B.D., Haas, W. and Gilmore, M.S. Enterococcus faecalis sense target cells and in response expresses cytolysin. Science306 2270.
13. Coque T.M., Patterson J.E., Steckelberg J.M., Murray B.E. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 1995, 171:1223-1229.
14. Davie J.M., Brock T.D. Action of streptolysin S, the group D hemolysin, and phospholipase C on whole cells and spheroplasts. The Journal of Bacteriology 1965, 91:595-600.
15. de Vuyst L., Vandamme E.J. Nisin, a lantibiotic produced by Lactococcus Lactis Subsp. Lactis: properties, biosynthesis, fermentation and applications. Bacteriocins of Lactic Acid Bacteria: Microbiology, Genetics, and Applications 1994, 151-200. Blackie Academic & Professional, London. L. de Vuyst, E.J. Vandamme (Eds.).
16. Dunny G.M., Clewell D.B. Transmissible toxin (hemolysin) plasmid in Streptococcus faecalis and its mobilization of a noninfectious drug resistance plasmid. The Journal of Bacteriology 1975, 124:784-790.
17. Dunny G.M., Leonard B.A. Cell-cell communication in Gram-positive bacteria. Annu. Rev. Microbiol. 1997, 51:527-564.
18. Dupont H., Montravers P., Mohler J., Carbon C. Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect. Immun. 1998, 66:2570-2575.
19. Elsner H.A., Sobottka I., Mack D., Claussen M., Laufs R., Wirth R. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:39-42.
20. Facklam R.R. Recognition of group D streptococcal species of human origin by biochemical and physiological tests. Appl. Microbiol. 1972, 23:1131-1139.
21. Fierer J., Guiney D.G. Diverse virulence traits underlying different clinical outcomes of Salmonella infection. J. Clin. Invest. 2001, 107:775-780.
22. Garsin D.A., Sifri C.D., Mylonakis E., Qin X., Singh K.V., Murray B.E., Calderwood S.B., Ausubel F.M. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 2001, 98:10892-10897.
23. Gentry-Weeks C.R., Karkhoff-Schweizer R., Pikis A., Estay M., Keith J.M. Survival of Enterococcus faecalis in mouse peritoneal macrophages. Infect. Immun. 1999, 67:2160-2165.
24. Gilmore M.S. Enterococcus faecalis hemolysin/bacteriocin. Genetics and Molecular Biology of Streptococci, Lactococci and Enterococci 1991, 206-213. American Society for Microbiology, London. G.M. Dunny, P.P. Cleary, L.L. McKay (Eds.).
25. Gilmore M.S., Coburn P.S., Nallapareddy S.R., Murray B.E. Enterococcal virulence. The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance 2002, 301-354. ASM Press, Washington, D.C. M.S. Gilmore, D.B. Clewell, P. Courvalin, G.M. Dunny, B.E. Murray, L.B. Rice (Eds.).
26. Gilmore M.S., Segarra R.A., Booth M.C. An HlyB-type function is required for expression of the Enterococcus faecalis hemolysin/bacteriocin. Infect. Immun. 1990, 58:3914-3923.
27. Gilmore M.S., Segarra R.A., Booth M.C., Bogie C.P., Hall L.R., Clewell D.B. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. The Journal of Bacteriology 1994, 176:7335-7344.
28. Granato P.A., Jackson R.W. Bicomponent nature of lysin from Streptococcus zymogenes. J. Bacteriol. 1969, 100:865-868.
29. Haas W., Shepard B.D., Gilmore M.S. Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 2002, 415:84-87.
30. Havarstein L.S., Diep D.B., Nes I.F. A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mcl. Microbiol. 1995, 16:229-240.
31. Huycke M.M., Gilmore M.S., Jett B.D., Booth J.L. Transfer of pheromone-inducible plasmids between Enterococcus faecalis in the Syrian hamster gastrointestinal tract. J. Infect. Dis. 1992, 166:1188-1191.
32. Huycke M.M., Joyce W.A., Gilmore M.S. Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice. J. Infect. Dis. 1995, 172:273-276.
33. Huycke M.M., Sahm D.F., Gilmore M.S. Multiple drug-resistant enterococci: the nature of the problem and an agenda for the future. Emerg. Infect. Dis. 1998, 4:239-249.
34. Huycke M.M., Spiegel C.A., Gilmore M.S. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 1991, 35:1626-1634.
35. Ike Y., Clewell D.B. Evidence that the hemolysin/bacteriocin phenotype of Enterococcus faecalis subsp. zymogenes can be determined by plasmids in different incompatibility groups, as well as by the chromosome. The Journal of Bacteriology 1992, 174:8172-8177.
36. Ike Y., Clewell D.B., Segarra R.A., Gilmore M.S. Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. The Journal of Bacteriology 1990, 172:155-163.
37. Ike Y., Hashimoto H., Clewell D.B. Hemolysin of Streptococcus faecalis subspecies zymogenes contributes to virulence in mice. Infect. Immun. 1984, 45:528-530.
38. Ike Y., Hashimoto H., Clewell D.B. High incidence of hemolysin production by Enterococcus (Streptococcus) faecalis strains associated with human parenteral infections. J. Clin. Microbiol. 1987, 25:1524-1528.
39. Jacob A.E., Douglas G.J., Hobbs S.J. Self-transferable plasmids determining the hemolysin and bacteriocin of Streptococcus faecalis var. zymogenes. The Journal of Bacteriology 1975, 121:863-872.
40. Jett B.D., Gilmore M.S. The growth-inhibitory effect of the Enterococcus faecalis bacteriocin encoded by pAD1 extends to the oral streptococci. J. Dent. Res. 1990, 69:1640-1645.
41. Jett B.D., Huycke M.M., Gilmore M.S. Virulence of enterococci. Clin. Microbiol. Rev. 1994, 7:462-478.
42. Jett B.D., Jensen H.G., Atkuri R.V., Gilmore M.S. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest. Ophthalmol. Vis. Sci. 1995, 36:9-15.
43. Jett B.D., Jensen H.G., Nordquist R.E., Gilmore M.S. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect. Immun. 1992, 60:2445-2452.
44. Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American surveillance study (2000-2002). Ann. Clin. Microbiol. Antimicrob. 2004, 3:14.
45. Kalmanson G.M., Hubert E.G., Guze L.B. Effect of bacteriocin from Streptococcus faecalis on microbial L-forms. J. Infect. Dis. 1970, 121:311-315.
46. Kellner R., Jung G., Josten M., Kaletta C., Entian K.-D., Sahl H.-G. Pep5, a new lantibiotic: structure elucidation and amino acid sequence of the propeptide. Angew. Chem. Int. Ed. Engl. 1989, 28:616-619.
47. Kobayashi R. Studies concerning hemolytic streptococci: typing of human hemolytic streptococci and their relation to diseases and their distribution on mucous membranes. Kitasato Arch. Exp. Med. 1940, 17:218-241.
48. Libertin C.R., Dumitru R., Stein D.S. The hemolysin/bacteriocin produced by enterococci is a marker of pathogenicity. Diagn. Microbiol. Infect. Dis. 1992, 15:115-120.
49. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu. Rev. Microbiol. 2001, 55:165-199.
50. Miyazaki S., Ohno A., Kobayashi I., Uji T., Yamaguchi K., Goto S. Cytotoxic effect of hemolytic culture supernatant from Enterococcus faecalis on mouse polymorphonuclear neutrophils and macrophages. Microbiol. Immunol. 1993, 37:265-270.
51. Navaratna M.A., Sahl H.G., Tagg J.R. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl. Environ. Microbiol. 1998, 64:4803-4808.
52. Navaratna M.A., Sahl H.G., Tagg J.R. Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect. Immun. 1999, 67:4268-4271.
53. Noble C.J. Carriage of group D streptococci in the human bowel. J. Clin. Pathol. 1978, 31:1182-1186.
54. Sherwood N.P., Russell B.E., Jay A.R., Bowman K. Studies on streptococci. III. New antibiotic substances produced by beta hemolytic streptococci. J. Infect. Dis. 1949, 84:88-91.
55. Rantz L.A., Kirby W.M.M. Enterococcic infections. An evaluation of the importance of fecal streptococci and related organisms in the causation of human disease. Arch. Intern. Med. 1943, 71:516-528.
56. Razeto A., Giller K., Haas W., Gilmore M.S., Zweckstetter M., Becker S. Expression, purification, crystallization, and preliminary crystallographic studies of the Enterococcus faecalis cytolysin repressor CylR2. Acta Crystallogr. D. Biol. Crystallogr. 2004, 60:746-748.
57. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect. Control Hosp. Epidemiol. 2000, 21:510-515.
58. Roelofsen B., De Gier J., Van Deenen L.L. Binding of lipids in the red cell membrane. J. Cell. Comp. Physiol. 1964, 63:233-243.
59. Rumpel S., Razeto A., Pillar C.M., Vijayan V., Taylor A., Giller K., Gilmore M.S., Becker S., Zweckstetter M. Structure and DNA-binding properties of the cytolysin regulator CylR2 from Enterococcus faecalis. EMBO J. 2004, 23:3632-3642.
60. Ryan M.P., Jack R.W., Josten M., Sahl H.G., Jung G., Ross R.P., Hill C. Extensive posttranslational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J. Biol. Chem. 1999, 274:37544-37550.
61. Ryan M.P., Rea M.C., Hill C., Ross R.P. An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl. Environ. Microbiol. 1996, 62:612-619.
62. Sahl H.G., Jack R.W., Bierbaum G. Biosynthesis and biological activities of lantibiotics with unique posttranslational modifications. Eur. J. Biochem. 1995, 230:827-853.
63. Segarra R.A., Booth M.C., Morales D.A., Huycke M.M., Gilmore M.S. Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect. Immun. 1991, 59:1239-1246.
64. Shankar N., Baghdayan A.S., Gilmore M.S. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature 2002, 417:746-750.
65. Stark J.M. Antibiotic activity of hemolytic enterococci. Lancet 1960, i:733-734.
66. Stevens S.X., Jensen H.G., Jett B.D., Gilmore M.S. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Invest. Ophthalmol. Vis. Sci. 1992, 33:1650-1656.
67. Todd E.W. A comparative serological study of streptolysins derived from human and from animal infections, with notes on pneumococcal hemolysin, tetanolysin, and staphylococcus toxin. J. Pathol. Bacteriol. 1934, 39:299-321.
68. Vergis E.N., Hayden M.K., Chow J.W., Snydman D.R., Zervos M.J., Linden P.K., Wagener M.M., Schmitt B., Muder R.R. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia, a prospective multicenter study. Ann. Intern. Med. 2001, 135:484-492.
69. Vergis E.N., Shankar N., Chow J.W., Hayden M.K., Snydman D.R., Zervos M.J., Linden P.K., Wagener M.M., Muder R.R. Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin. Infect. Dis. 2002, 35:570-575.
70. Wiedemann I., Benz R., Sahl H.G. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. The Journal of Bacteriology 2004, 186:3259-3261.
71. Willems R.J., Top J., van Den B.N., van Belkum A., Endtz H., Mevius D., Stobberingh E., van Den B.A., van Embden J.D. Host specificity of vancomycin-resistant Enterococcus faecium. J. Infect. Dis. 2000, 182:816-823.